GLP-1 receptor agonists for obstructive sleep apnea: a meta-analysis of randomized controlled trials
The take-home point: this paper sharpens how Dr. Nord's practice counsels patients about weight and surgery, even though it doesn't change who is offered surgery. The decision it touches is the conversation with a patient who carries excess weight and is considering Inspire or barbed reposition pharyngoplasty, BRP. In Dr. Nord's practice, weight loss, including GLP-1 drugs, is part of multimodal treatment of obstructive sleep apnea alongside Inspire, often both rather than either-or. Many Inspire patients are already on these drugs or will become candidates for them. So quote the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.